Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Eddy Robberecht"'
Autor:
Laurens Hermie, Stephanie Van Biervliet, Anne Hoorens, Lien Van Cauwenberghe, Eddy Robberecht, Luc Defreyne
Publikováno v:
Diagnostic and Interventional Radiology, Vol 30, Iss 1, Pp 55-64 (2024)
PURPOSE: Portal hypertension (PHT) and its sequelae are the most clinically important manifestations in cystic fibrosis-related liver disease (CFLD). This paper aimed to evaluate the safety and efficacy of a pre-emptive transjugular intrahepatic port
Externí odkaz:
https://doaj.org/article/b76d53dffa474c6abadd85fb11d0e658
Autor:
Laurens Hermie, Stephanie Van Biervliet, Anne Hoorens, Lien Van Cauwenberghe, Eddy Robberecht, Luc Defreyne
Publikováno v:
Diagnostic and Interventional Radiology.
Autor:
Jesse Vanbesien, Inge Roggen, Sabine Van daele, Elke De Wachter, Stephanie Van Biervliet, Inge Gies, Eddy Robberecht, Anne Malfroot, Kathleen De Waele, Olivia Louis, Jean De Schepper
Publikováno v:
Ultrasound in Medicine & Biology. 41:334-338
It is of clinical importance to identify bone disease related to cystic fibrosis (CF) early in its course to allow therapeutic interventions that optimize bone health. To test the technical (precision) and clinical (percentage of abnormal results, co
Publikováno v:
Nutrition in Clinical Practice. 30:134-137
Background The etiology of distal intestinal obstruction syndrome (DIOS) remains unclear. Food intake and pancreatic enzyme replacement therapy (PERT) are often blamed for its occurrence. This study evaluates the nutrition intake and PERT of patients
Autor:
Stéphane M. Schneider, Carla Colombo, Martin Stern, Birgitta Strandvik, Alison Morton, Dominique Turck, Sue Wolfe, Ruzha Pancheva, Dimitri Declercq, Michael Wilschanski, Eddy Robberecht, Christian Braegger
Malnutrition is both a frequent feature and a comorbidity of cystic fibrosis (CF), with nutritional status strongly associated with pulmonary function and survival. Nutritional management is therefore standard of care in CF patients. ESPEN, ESPGHAN a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c78addbb4ace4c2acb4f963ade3b6bc
https://doi.org/10.5167/uzh-134099
https://doi.org/10.5167/uzh-134099
Publikováno v:
European Journal of Clinical Nutrition. 65:574-579
Background/Objectives:The increase of bone disease in adult cystic fibrosis (CF) patients is partly attributed to inadequate serum concentrations of 25-OH cholecalciferol (25 (OH) D) blamed on fat malabsorption. Based on physiological, clinical and b
Publikováno v:
cclm. 48:1751-1755
Background: In cystic fibrosis (CF), changes in fatty acid (FA) composition of serum phospholipids (PL) and cell membranes can account, in part, for the inflammatory state of the disease. The severity of the genotype is known to correlate with the de
Publikováno v:
Current Pediatric Reviews. 5:184-188
Zinc (Zn) is a multipurpose trace element, sufficiency of which is difficult to assess. However, Zn deficiency could negatively influence this disease in different aspects. The symptoms of Zn deficiency as taste disturbances, decreased appetite and i
Publikováno v:
BIOLOGICAL TRACE ELEMENT RESEARCH
Aim: Assess the risk of zinc (Zn) deficiency in the older cystic fibrosis (CF) population. Method: Cross-sectional investigation of all CF patients above the age of 4 followed at the Ghent University center between 2002 and 2003. Data on age, weight,
Autor:
Eddy Robberecht, Dimitri Declercq, Stephanie Van Biervliet, Armand Christophe, Jean-Pierre Van Biervliet, Griet Vanbillemont
Publikováno v:
Annals of Nutrition and Metabolism. 51:541-549
Objective: To evaluate the relation of clinical parameters and genotype with the serum phospholipid fatty acid (FA) composition in cystic fibrosis (CF) patients. Methods: A blood sample was taken from CF patients with stable pulmonary disease for the